Abstract
Purpose
To assess pregnancy outcome in women with Alport syndrome and the impact of pregnancy on the disease progression.
Methods
We describe one of the largest series of pregnancies in Alport syndrome. Seven pregnancies of six women were monitored by a multidisciplinary team of nephrologists and gynecologists. After delivery, patients were followed for at least 3 years. We compare our results with those in the literature.
Results
Pregnancy course was uneventful in the patient with isolated microscopic hematuria. In the other cases, all presenting mild proteinuria at conception, some complications occurred. Proteinuria worsened during the last trimester, reaching nephrotic ranges in five out of six pregnancies and was associated with fluid overload leading to hospitalizations and early delivery. The majority of the newborns had a low birth weight. The two patients with arterial hypertension at conception and twin pregnancy developed pre-eclampsia and renal function deterioration persisted after delivery. The one with pre-pregnancy renal dysfunction reached end-stage renal disease. In the other patients, in which renal function and blood pressure were and remained normal, proteinuria improved after delivery and no signs of disease progression were recorded at last observation.
Conclusions
Our observations suggest that Alport syndrome should be considered a potential risk factor for pregnancy in proteinuric patients due to the development of pre-eclampsia, renal function deterioration, and/or full-blown nephrotic syndrome that results in anasarca, slowing of fetal growth and pre-term delivery. Thus, all women with Alport syndrome should receive pre-conceptional counseling and be kept in close follow-up during pregnancy.
Similar content being viewed by others
References
Savige J, Colville D, Rheault M, Gear S, Lennon R, Lagas S, Finlay M, Flinter F (2016) Alport syndrome in women and girls. Clin J Am Soc Nephrol 11:1713–1720
Cosgrove D, Liu S (2017) Collagen IV diseases: a focus on the glomerular basement membrane in Alport syndrome. Matrix Biol 57–58:45–54
Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG (2003) Alport’s syndrome, Goodpasture’s syndrome, and type IV collagen. New Engl J Med 348:2543–2556
Kashtan CE (2001) Alport syndrome and thin basement membrane nephropathy (last updated 2015 Nov 25) gene reviews. University of Washington, Seattle
Morinière V, Dahan K, Hilbert P, Lison M, Lebbah S, Topa A, Bole-Feysot C, Pruvost S, Nitschke P, Plaisier E, Knebelmann B, Macher MA, Noel LH, Gubler MC, Antignac C, Heidet L (2014) Improving mutation screening in familial hematuric nephropathies through next generation sequencing. J Am Soc Nephrol 25:2740–2751
Fallerini C, Dosa L, Tita R, Del Prete D, Feriozzi S, Gai G, Clementi M, La Manna A, Miglietti N, Mancini R, Mandrile G, Ghiggeri GM, Piaggio G, Brancati F, Diano L, Frate E, Pinciaroli AR, Giani M, Castorina P, Bresin E, Giachino D, De Marchi M, Mari F, Bruttini M, Renieri A, Ariani F (2014) Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases. Clin Genet 86:252–257
Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer K-O, Flinter F, Pirson Y, Verellen C, Wieslander JR, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2000) X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol 11:649–657
Bekheirnia MR, Reed B, Gregory MC (2010) Genotype-phenotype correlation in X-linked Alport syndrome. J Am Soc Nephrol 21:876–883
Rheault MN (2012) Women and Alport syndrome. Pediatr Nephrol 27:41–46
Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer K-O, Flinter F, Pirson Y, Dahan K, Wieslander JR, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2003) X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a “European Community Alport Syndrome Concerted Action” study. J Am Soc Nephrol 14:2603–2610
Yefet E, Tovbin D, Nachum Z (2016) Pregnancy outcomes in patients with Alport syndrome. Arch Gynaecol Obstet 293:739–747
Crovetto F, Moroni G, Zaina B, Acaia B, Ossola MW, Fedele L (2013) Pregnancy in women with Alport syndrome. Int Urol Nephrol 45:1223–1227
Nevis IF, Reitsma A, Dominic A, McDonald S, Thabane L, Akl EA, Hladunewich M, Akbari A, Joseph G, Sia W, Iansavichus AV, Garg AX (2011) Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin J Am Soc Nephrol 6:2587–2598
Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC (2014) Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ 348:g2301
Cabiddu G, Castellino S, Gernone G, Moroni G, Giannattasio M, Gregorini G, Giacchino F, Attini R, Loi V, Limardo M, Gammaro L, Todros T, Piccoli GB (2016) A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on kidney and pregnancy. J Nephrol 29:277–303
Matsuo K, Tudor EL, Baschat AA (2007) Alport syndrome and pregnancy. Obstet Gynecol 109:531–532
Mehta S, Saifan C, Abdellah M, Choueiry R, Nasr R, El-Sayegh S (2013) Alport’s syndrome in pregnancy. Case Rep Med. https://doi.org/10.1155/2013/374020
Kitanovska BG, Gerasimovska V, Livrinova V (2016) Two pregnancies with a different outcome in a patient with Alport syndrome. Open Access Maced J Med Sci 4(3):439–442
Alessi M, Fabris A, Zambon A, Cremasco D, Murar o E, Dosa L (2014) Pregnancy in Alport syndrome: a report of two differently-evolving cases. J Obstet Gynaecol 34(1):98–100
Nishizawa Y, Takei T, Miyaoka T, Kamei D, Mochizuki T, Nitta K (2016) Alport syndrome and pregnancy: good obstetric and nephrological outcomes in a pregnant woman with homozygous autosomal recessive Alport syndrome. J Obstet Gynaecol Res 42(3):331–335
Matsubara S, Ueda Y, Takahashi H, Nagai T, Kuwata T, Muto S, Yamaguchi T, Takizawa T, Suzuki M (2009) Pregnancy complicated with Alport syndrome: a good obstetric outcome and failure to diagnose an infant born to a mother with Alport syndrome by umbilical cord immunofluorescence staining. J Obstet Gynaecol Res 35(6):1109–1114
Matsubara S, Muto S (2012) Good obstetric outcome of consecutive pregnancies in a woman with Alport syndrome. Arch Gynecol Obstet 286:261–262
Bramham K, Lightstone L (2012) Pre-pregnancy counseling for women with chronic kidney disease. J Nephrol 25(04):450–459
Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW (2012) Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol 8:293–300
Sibai BM, Villar MA, Mabie BC (1990) Acute renal failure in hypertensive disorders of pregnancy: pregnancy outcome and remote prognosis in thirty-one consecutive cases. Am J Obstet Gynecol 162:777–783
Funding
No supplemental funding was provided for this research.
Author information
Authors and Affiliations
Contributions
FB data collection, data analysis, and manuscript writing/editing. BZ clinical assessment of mothers and fetus during pregnancy and patient follow-up. DG data collection. WO clinical assessment of mothers and fetus during pregnancy and patient follow-up. MG patient follow-up at diagnosis. LF paper assessment. PGM paper assessment. GM project development; clinical assessment of mothers and fetus during pregnancy and patient follow-up; data analysis and manuscript writing/editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the IRCCS Ca’ Granda Ospedale Maggiore Policlinico ethics committee-Milano area B- and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
Informed consent
Data were collected retrospectively in an anonymous database without interfering with the best clinical practice at any time during patients’ follow-up. Due to the retrospective nature of the study, neither written nor verbal informed consent was necessary, according to the ethical standards of the institutional Ethics Committee.
Rights and permissions
About this article
Cite this article
Brunini, F., Zaina, B., Gianfreda, D. et al. Alport syndrome and pregnancy: a case series and literature review. Arch Gynecol Obstet 297, 1421–1431 (2018). https://doi.org/10.1007/s00404-018-4720-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-018-4720-x